Correction to: Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis
An amendment to this paper has been published and can be accessed via the original article.
Guardado en:
Autores principales: | Michaël Doumen, Diederik De Cock, Sofia Pazmino, Delphine Bertrand, Johan Joly, René Westhovens, Patrick Verschueren |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1ecab87a5d7e4cf5a239645210c3ae35 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy, safety, and tolerability of abatacept in the management of rheumatoid arthritis
por: Joseph R Lutt
Publicado: (2009) -
Critical appraisal of efficacy and safety of abatacept in the treatment of refractory rheumatoid arthritis
por: Augustine JM, et al.
Publicado: (2012) -
Rheumatoid arthritis: Disease or syndrome?
por: Jessica A Stanich, et al.
Publicado: (2009) -
Reappraisal of the clinical use of leflunomide in rheumatoid arthritis and psoriatic arthritis
por: Peter BB Jones, et al.
Publicado: (2010) -
Genetics of rheumatoid arthritis: GWAS and beyond
por: McAllister KM, et al.
Publicado: (2011)